0.60 USD
↘ 0.01 (1.35%)AT CLOSE (11:59 AM EDT)
Enlivex Ltd. Ordinary Shares
ENLVNASDAQ • USD
0.62
↗ 0.02 (3.77%)
POST MARKET (AS OF 07:44 PM EDT)
Post Market
AS OF 07:44 PM EDT
0.62
↗ 0.02 (3.77%)
Market: CLOSED
ENLV is currently priced at $0.60. The technical outlook is "Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest ENLV is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Sep 25, 2026.
Open?$0.60
High?$0.62
Low?$0.58
Prev. Close?$0.61
Volume?317.5K
Avg. Volume?356.6K
VWAP?$0.60
Rel. Volume?0.89x
Bid / Ask
Bid?$0.60 × 900
Ask?$0.62 × 3.9K
Spread?$0.02
Midpoint?$0.61
Valuation & Ratios
Market Cap?10.5M
Shares Out?17.5M
Float?32.2M
Float %?13.3%
P/E Ratio?N/A
P/B Ratio?0.30
EPS?-$0.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?100
Piotroski F-Score?0/9Weak
Altman Z-Score?6.44Safe
Confidence?40%Low
Short InterestLow
Short % of Float?0.15%Low
Short Interest?48.2K
Days to Cover?1.0
Free Float32.2M
Avg Daily Volume259.9K
Settlement Date2026-09-15
Financial Health
Current Ratio?8.72Strong
Quick Ratio?8.72Strong
Cash Ratio?1.30Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.30CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-23.7%WEAK▾
S&P7
ROA?-20.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$4.8M
Fundamentals ratios updated end of day